Arkolith/Insider Trading/IKT/Form 4

Sands Frank M.

10% OwnerInhibikase Therapeutics, Inc. (IKT) · full profile →Form 4 · filed Nov 24, 2025
Net Buying
Open-Market Buys
$3.0M
Open-Market Sells
$0
Net Open-Market Flow
$3.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2025Buy(P)2.1M$1.45$3.0M13.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001875620-25-000025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML